Table of Contents Table of Contents
Previous Page  50 / 364 Next Page
Information
Show Menu
Previous Page 50 / 364 Next Page
Page Background

DANONE

REGISTRATION DOCUMENT 2015

Danone's business highlights in 2015 and outlook for 2016

3.2 Consolidated net income review

50

3.2 CONSOLIDATED NET INCOME REVIEW

Year ended December 31

(in € millions unless otherwise

indicated)

2014

2015

Change as reported Change Like-for-like

Sales

21,144

22,412

+6.0%

+4.4%

Trading operating income

(a)

2,662

2,892

+8.7%

+5.7%

Trading operating margin

(a)

12.59%

12.91%

+32 bps

+17 bps

Recurring net income

– Group share

(a)

1,561

1,791

+14.7%

+9.1%

Net income – Group share

1,119

1,282

+14.6%

+7.4%

Recurring EPS

(in €)

(a)

2.62

2.93

+12.0%

+6.5%

EPS

(in €)

1.88

2.10

+11.9%

Free cash flow excluding

exceptional items

(a)

1,401

1,529

+9.2%

(a) See definition section 3.6

Financial indicators not defined by IFRS.

Sales

Consolidated sales

Consolidated sales stood at €22,412 million in 2015, up +6.0% from

the figures reported in 2014. Excluding the impact of changes in the

basis for comparison (i.e. exchange rates and scope of consolidation)

sales were up +4.4%. This organic growth reflects a +0.9% rise in

volume and a +3.5% rise in value.

The +2.0%exchange-rate effect reflects favorable trends in currencies

including the US dollar, the Chinese Yuan and the British Pound.

The -0.4% impact of the change in scope of consolidation results

primarily from the deconsolidation in July 2014 of Fresh Dairy

Products operations in China, and the sale in December 2014 of

the Fresh Dairy Products business in Indonesia.

Sales by Division

Year ended December 31

(in € millions except percentage)

2014

2015

Change

(a)

Volume growth

(a)

Fresh Dairy Products

11,129

11,057

+0.6%

-3.0%

Waters

4,186

4,768

+7.1%

+5.1%

Early Life Nutrition

4,397

4,994

+9.8%

+4.7%

Medical Nutrition

1,432

1,593

+7.5%

+4.7%

Total

21,144

22,412

+4.4%

+0.9%

(a) Like-for-like.